WY, J., CC, L., CS, C., & WT, L. (2026). Comparative effects of SGLT2 inhibitors and GLP-1 receptor agonists on osteoarthritis risk in patients with type 2 diabetes mellitus: A multi-institutional cohort study. PloS one, 21(7), e0353956. https://doi.org/10.1371/journal.pone.0353956
Chicago Style (17th ed.) CitationWY, Jao, Lai CC, Chien CS, and Lin WT. "Comparative Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Osteoarthritis Risk in Patients with Type 2 Diabetes Mellitus: A Multi-institutional Cohort Study." PloS One 21, no. 7 (2026): e0353956. https://doi.org/10.1371/journal.pone.0353956.
MLA (9th ed.) CitationWY, Jao, et al. "Comparative Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Osteoarthritis Risk in Patients with Type 2 Diabetes Mellitus: A Multi-institutional Cohort Study." PloS One, vol. 21, no. 7, 2026, p. e0353956, https://doi.org/10.1371/journal.pone.0353956.